Skip to main content
Full access
New Research
Published Online: 1 April 2014

Repeated Δ9-Tetrahydrocannabinol Exposure in Adolescent Monkeys: Persistent Effects Selective for Spatial Working Memory

Abstract

Adolescent rhesus monkeys administered D9-tetrahydrocannabinol (THC) 5 days a week for 6 months showed less practice-related improvement than unexposed monkeys on a test measuring working memory of spatial relationships. The exposed and unexposed monkeys did not differ in memory of colored objects. The discrepancy between spatial and object memory effects may stem from different developmental trajectories of underlying brain circuits.

Abstract

Objective

Epidemiological findings suggest that, relative to adults, adolescents are more vulnerable to the adverse persistent effects of cannabis on working memory. However, the potential confounds inherent in human studies preclude direct determination of a cause-and-effect relationship between adolescent cannabis use and heightened susceptibility to persistent working memory impairments. Consequently, the authors examined the effects of repeated exposure to Δ9-tetrahydrocannabinol (THC) on performance of spatial and object working memory tasks in adolescent monkeys.

Method

Seven pairs of male adolescent rhesus monkeys, matched for baseline cognitive performance, received vehicle or THC intravenously 5 days/week for 6 months. Performance on spatial and object memory tasks was assessed 23 or 71 hours after drug administration throughout the study. In addition, acute effects on working memory were also assessed at the beginning and end of the 6-month period.

Results

Relative to the vehicle-exposed control animals, those with repeated THC exposure had a blunted trajectory of accuracy improvements on the spatial working memory task in a delay-dependent manner. Accuracy improvements on the object working memory task did not differ between groups. Relative to the acute effects of THC on working memory at the beginning of the study, neither sensitivity nor tolerance was evident after 6 months of THC exposure.

Conclusions

Because maturation of performance is later for spatial than for object working memory, these findings suggest that persistent effects of THC on cognitive abilities are more evident when exposure coincides with the developmental stage during which the underlying neural circuits are actively maturing.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 416 - 425
PubMed: 24577206

History

Received: 11 March 2013
Revision received: 2 November 2013
Accepted: 18 November 2013
Published online: 1 April 2014
Published in print: April 2014

Authors

Details

Christopher D. Verrico, Ph.D.
From the Departments of Psychiatry, Statistics, and Neuroscience, University of Pittsburgh.
Hong Gu, M.S.
From the Departments of Psychiatry, Statistics, and Neuroscience, University of Pittsburgh.
Melanie L. Peterson, B.S.
From the Departments of Psychiatry, Statistics, and Neuroscience, University of Pittsburgh.
Allan R. Sampson, Ph.D.
From the Departments of Psychiatry, Statistics, and Neuroscience, University of Pittsburgh.
David A. Lewis, M.D.
From the Departments of Psychiatry, Statistics, and Neuroscience, University of Pittsburgh.

Notes

Presented in part at the 2010 annual meeting of the Society for Neuroscience, San Diego, Oct. 13–17, 2010, and the 49th annual meeting of the American College of Neuropsychopharmacology, Miami Beach, Fla., Dec. 5–9, 2010.
Address correspondence to Dr. Verrico ([email protected]) or Dr. Lewis ([email protected]).

Funding Information

Dr. Sampson is a consultant in statistical design to Janssen Pharmaceutical Research and Development, a Janssen Pharmaceutical Company. Dr. Lewis currently receives investigator-initiated research support from Bristol-Myers Squibb, Curridium, and Pfizer and in 2011–2013 served as a consultant in the areas of target identification and validation and new compound development to Bristol-Myers Squibb and Concert Pharmaceuticals. Dr. Verrico, Ms. Gu, and Ms. Peterson report no financial relationship with commercial interests.
Supplementary Material
Supported by National Institute on Drug Abuse grant DA-023109 and by a NARSAD Distinguished Investigator award to Dr. Lewis.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share